You can seek FDA approval to launch a generic drug before the expiration of OZEMPIC's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the OZEMPIC's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Here are the details of the already filed Para IV certificates on OZEMPIC:-

You can seek FDA approval to launch a generic drug before the expiration of LUMIFY's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the LUMIFY's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Here are the details of the already filed Para IV certificates on LUMIFY:-

You can seek FDA approval to launch a generic drug before the expiration of ELCYS's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the ELCYS's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Here are the details of the already filed Para IV certificates on ELCYS:-

You can seek FDA approval to launch a generic drug before the expiration of IMBRUVICA's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the IMBRUVICA's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Here are the details of the already filed Para IV certificates on IMBRUVICA:-

You can seek FDA approval to launch a generic drug before the expiration of ARAZLO's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the ARAZLO's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Here are the details of the already filed Para IV certificates on ARAZLO:-

You can seek FDA approval to launch a generic drug before the expiration of WEGOVY's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the WEGOVY's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Here are the details of the already filed Para IV certificates on WEGOVY:-

You can seek FDA approval to launch a generic drug before the expiration of MAVENCLAD's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the MAVENCLAD's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Here are the details of the already filed Para IV certificates on MAVENCLAD:-

You can seek FDA approval to launch a generic drug before the expiration of ONUREG's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the ONUREG's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Here are the details of the already filed Para IV certificates on ONUREG:-

You can seek FDA approval to launch a generic drug before the expiration of CALQUENCE's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the CALQUENCE's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Here are the details of the already filed Para IV certificates on CALQUENCE:-

You can seek FDA approval to launch a generic drug before the expiration of VENCLEXTA's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the VENCLEXTA's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Here are the details of the already filed Para IV certificates on VENCLEXTA:-

You can seek FDA approval to launch a generic drug before the expiration of TRULANCE's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the TRULANCE's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Here are the details of the already filed Para IV certificates on TRULANCE:-

You can seek FDA approval to launch a generic drug before the expiration of XARELTO's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the XARELTO's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Here are the details of the already filed Para IV certificates on XARELTO:-

A supplementary protection certificate (SPC) is a type of intellectual property right granted in the European Union. It provides an extension of the term of protection for a medicinal product that has been authorized for sale in the EU, beyond the 20-year term provided by the basic patent.

The aim of SPCs is to compensate for the time taken to get regulatory approval for a new drug, and to provide an incentive for companies to invest in research and development in the field of medicinal products.

You can seek FDA approval to launch a generic drug before the expiration of TIBSOVO's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the TIBSOVO's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Here are the details of the already filed Para IV certificates on TIBSOVO:-

You can seek FDA approval to launch a generic drug before the expiration of SAXENDA's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the SAXENDA's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Here are the details of the already filed Para IV certificates on SAXENDA:-

You can seek FDA approval to launch a generic drug before the expiration of VICTOZA's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the VICTOZA's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Here are the details of the already filed Para IV certificates on VICTOZA:-

You can seek FDA approval to launch a generic drug before the expiration of VASCEPA's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the VASCEPA's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Here are the details of the already filed Para IV certificates on VASCEPA:-

You can seek FDA approval to launch a generic drug before the expiration of PEDMARK's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the PEDMARK's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Here are the details of the already filed Para IV certificates on PEDMARK:-

You can seek FDA approval to launch a generic drug before the expiration of THIOLA EC's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the THIOLA EC's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Here are the details of the already filed Para IV certificates on THIOLA EC:-

You can seek FDA approval to launch a generic drug before the expiration of AUSTEDO's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the AUSTEDO's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Here are the details of the already filed Para IV certificates on AUSTEDO:-

You can seek FDA approval to launch a generic drug before the expiration of CHANTIX's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the CHANTIX's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Here are the details of the already filed Para IV certificates on CHANTIX:-

You can seek FDA approval to launch a generic drug before the expiration of TYVASO's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the TYVASO's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Here are the details of the already filed Para IV certificates on TYVASO:-

You can seek FDA approval to launch a generic drug before the expiration of CERDELGA's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the CERDELGA's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Here are the details of the already filed Para IV certificates on CERDELGA:-

You can seek FDA approval to launch a generic drug before the expiration of ENTRESTO's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the ENTRESTO's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Here are the details of the already filed Para IV certificates on ENTRESTO:-

You can seek FDA approval to launch a generic drug before the expiration of NAPROXEN SODIUM's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the NAPROXEN SODIUM's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Here are the details of the already filed Para IV certificates on NAPROXEN SODIUM:-

You can seek FDA approval to launch a generic drug before the expiration of JANUMET's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the JANUMET's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Here are the details of the already filed Para IV certificates on JANUMET:-

You can seek FDA approval to launch a generic drug before the expiration of JANUMET XR's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the JANUMET XR's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Here are the details of the already filed Para IV certificates on JANUMET XR:-